|
1
|
Marson A, Kretschmer K, Frampton GM,
Jacobsen ES, Polansky JK, MacIsaac KD, Levine SS, Fraenkel E, von
Boehmer H and Young RA: Foxp3 occupancy and regulation of key
target genes during T-cell stimulation. Nature. 445:931–935. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Gavin MA, Rasmussen JP, Fontenot JD, Vasta
V, Manganiello VC, Beavo JA and Rudensky AY: Foxp3-dependent
programme of regulatory T-cell differentiation. Nature.
445:771–775. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Sakaguchi S: Immunology: Conditional
stability of T cells. Nature. 468:41–42. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hinz S, Pagerols-Raluy L, Oberg HH,
Ammerpohl O, Grüssel S, Sipos B, Grützmann R, Pilarsky C,
Ungefroren H, Saeger HD, et al: Foxp3 expression in pancreatic
carcinoma cells as a novel mechanism of immune evasion in cancer.
Cancer Res. 67:8344–8350. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Merlo A, Casalini P, Carcangiu ML,
Malventano C, Triulzi T, Mènard S, Tagliabue E and Balsari A: FOXP3
expression and overall survival in breast cancer. J Clin Oncol.
27:1746–1752. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zuo T, Wang L, Morrison C, Chang X, Zhang
H, Li W, Liu Y, Wang Y, Liu X, Chan MW, et al: FOXP3 is an X-linked
breast cancer suppressor gene and an important repressor of the
HER-2/ErbB2 oncogene. Cell. 129:1275–1286. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ladoire S, Arnould L, Mignot G, Coudert B,
Rébé C, Chalmin F, Vincent J, Bruchard M, Chauffert B, Martin F, et
al: Presence of Foxp3 expression in tumor cells predicts better
survival in HER2-overexpressing breast cancer patients treated with
neoadjuvant chemotherapy. Breast Cancer Res Treat. 125:65–72. 2011.
View Article : Google Scholar
|
|
8
|
Wang L, Liu R, Li W, Chen C, Katoh H, Chen
GY, McNally B, Lin L, Zhou P, Zuo T, et al: Somatic single hits
inactivate the X-linked tumor suppressor FOXP3 in the prostate.
Cancer Cell. 16:336–346. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wu Y, Borde M, Heissmeyer V, Feuerer M,
Lapan AD, Stroud JC, Bates DL, Guo L, Han A, Ziegler SF, et al:
FOXP3 controls regulatory T cell function through cooperation with
NFAT. Cell. 126:375–387. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Bettelli E, Dastrange M and Oukka M: Foxp3
interacts with nuclear factor of activated T cells and NF-kappa B
to repress cytokine gene expression and effector functions of T
helper cells. Proc Natl Acad Sci USA. 102:5138–5143. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chaudhry A, Rudra D, Treuting P, Samstein
RM, Liang Y, Kas A and Rudensky AY: CD4+ regulatory T
cells control TH17 responses in a Stat3-dependent manner. Science.
326:986–991. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ono M, Yaguchi H, Ohkura N, Kitabayashi I,
Nagamura Y, Nomura T, Miyachi Y, Tsukada T and Sakaguchi S: Foxp3
controls regulatory T-cell function by interacting with AML1/Runx1.
Nature. 446:685–689. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chen C, Rowell EA, Thomas RM, Hancock WW
and Wells AD: Transcriptional regulation by Foxp3 is associated
with direct promoter occupancy and modulation of histone
acetylation. J Biol Chem. 281:36828–36834. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li B, Samanta A, Song X, Iacono KT, Bembas
K, Tao R, Basu S, Riley JL, Hancock WW, Shen Y, et al: FOXP3
interactions with histone acetyltransferase and class II histone
deacetylases are required for repression. Proc Natl Acad Sci USA.
104:4571–4576. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zheng Y, Josefowicz SZ, Kas A, Chu TT,
Gavin MA and Rudensky AY: Genome-wide analysis of Foxp3 target
genes in developing and mature regulatory T cells. Nature.
445:936–940. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Rudra D, deRoos P, Chaudhry A, Niec RE,
Arvey A, Samstein RM, Leslie C, Shaffer SA, Goodlett DR and
Rudensky AY: Transcription factor Foxp3 and its protein partners
form a complex regulatory network. Nat Immunol. 13:1010–1019. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Liang YJ, Liu HC, Su YX, Zhang TH, Chu M,
Liang LZ and Liao GQ: Foxp3 expressed by tongue squamous cell
carcinoma cells correlates with clinicopathologic features and
overall survival in tongue squamous cell carcinoma patients. Oral
Oncol. 47:566–570. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Sadlon TJ, Wilkinson BG, Pederson S, Brown
CY, Bresatz S, Gargett T, Melville EL, Peng K, D’Andrea RJ, Glonek
GG, et al: Genome-wide identification of human FOXP3 target genes
in natural regulatory T cells. J Immunol. 185:1071–1081. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang X and Seed B: A PCR primer bank for
quantitative gene expression analysis. Nucleic Acids Res.
31:e1542003. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Hancock WW and Ozkaynak E: Three distinct
domains contribute to nuclear transport of murine Foxp3. PLoS One.
4:e78902009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Medzhitov R: Inflammation 2010: New
adventures of an old flame. Cell. 140:771–776. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Cantini G, Pisati F, Mastropietro A,
Frattini V, Iwakura Y, Finocchiaro G and Pellegatta S: A critical
role for regulatory T cells in driving cytokine profiles of Th17
cells and their modulation of glioma microenvironment. Cancer
Immunol Immunother. 60:1739–1750. 2011. View Article : Google Scholar : PubMed/NCBI
|
